Pfizer

Linezolid

Manufacturer:

Pfizer

Linezolid HCPCS:

J2021

HCPCS Code Descriptor:

Injection, linezolid (hospira) not therapeutically equivalent to j2020, 200 mg

Category:

J Code

Linezolid NDCs:

00409-4883-01, 00409-4883-10

Primary Type:

Antibiotic

Generic/Specialty Status:

Single-Source

Package Type:

Bag

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00409-4883-01, 00409-4883-10

About Linezolid:

Linezolid is an Antibiotic drug manufactured by Pfizer and administered via the Intravenous route of administration. The J Code: J2021 is aligned to the drug Linezolid.

ACCESS PRICING AND MORE BY REGISTERING

J2021 Added Date:

January 1, 2023

J2021 Effective Date:

January 1, 2023

J2021 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Linezolid billing and coding information.
Linezolid patient assistance information can be found through Pfizer Rx Pathways at the URL: https://www.pfizerrxpathways.com/
Linezolid prescribing information can be found at the link below:
Information regarding Linezolid’s side effects can be found at MedlinePlus